About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Majority Eastern Europe Still Affected by Tuberculosis

by Manisha Shroff on March 18, 2015 at 5:15 PM
Font : A-A+

Majority Eastern Europe Still Affected by Tuberculosis

Despite a drastic decrease in tuberculosis, roughly 1,000 people still contract it daily in Europe and Central Asia, a report by the Europe Centre for Disease Prevention and Control (ECDC) revealed Tuesday.

The report, co-authored with the World Health Organization (WHO), said the continent would not be free of the disease until the next century at the current low rate of eradication, particularly due to prevalence in countries to the east of the region.

Advertisement

"Multi-resistance tuberculosis (MDR-TB) is still ravaging the European region, making it the most affected area of the entire world," Zsuzsanna Jakab, WHO regional director for Europe, said in a statement.

She noted that 50 percent of cases are reported and only half of those are successfully cured.

Overall cases of the disease in the vast region -- stretching from Ireland to Russia -- fell by 5.6 percent between 2012 and 2013.
Advertisement

In 2013, there were about 360,000 reported tuberculosis cases with 85 percent occurring in 18 "high priority" countries in Eastern Europe and Central Asia, including Romania, Georgia, Turkey, Uzbekistan, Kazakhstan and Russia.

Most of the 38,000 deaths from the disease were also in Eastern Europe and in former Soviet republics.

"TB disease is closely associated with the socio-economic conditions in a country, e.g. nutrition, living standards, health systems," ECDC spokeswoman Marieke van der Werf told AFP by email.

"It has been shown that in Europe, TB notifications are higher where national incomes are lower and/or income inequalities are higher."

The low detection rate and recovery from the disease in many countries mean health authorities need to considerably "scale up access to safe, rational and efficient new TB drugs, as well as innovations on rapid diagnosis and care," added Zsuzsanna Jakab at the WHO.

Tuberculosis is the world's second most deadly infectious disease after AIDS with 1.5 million deaths recorded in 2013 compared to 1.6 million AIDS-related deaths in 2012.

World TB Day is marked each year on March 24 in an effort to raise awareness of prevention and treatment.

Source: Medindia
Advertisement

Advertisement
Advertisement

Recommended Readings

Latest Cancer News

Combination Therapy may Benefit Leukemia Patients
The new study uncovers the efficacy of fixed-duration combination treatment in patients with high-risk leukemia.
 Myelofibrosis: New Drugs to Revolutionize Treatment
The approvals of pipeline drugs such as momelotinib and Vonjo for myelofibrosis (a rare type of blood cancer) over some time will handle the critical unmet needs.
 Blood Vessels Can Kill Cancer Cells and Stop Breast Cancer Spread
New study highlights the dual role that blood vessels can play in cancer immunotherapy and eliciting anti-tumor immune responses or even preventing breast cancer spread.
 Weed Killer Agent Orange May Increase the Risk of Blood Cancer Among Veterans
New study evaluated the association between exposure to the chemical agent orange and the development of blood cancer with increased bleeding and blood clot formation.
Two Years: Optimal Duration of Immunotherapy in Advanced Lung Cancer
Study suggests two-year immunotherapy treatment for advanced lung cancer may be reasonable
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

Majority Eastern Europe Still Affected by Tuberculosis Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests